|
| TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||||||||||||
| October 2012 Volume 12 Number 10 | |||||||||||||||||||||||||||||||||||||||||||||||
| In this issue
| ||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| REVIEWS | Top | ||||||||||||||||||||||||||||||||||||||||||||||
| Evolutionary conflicts between viruses and restriction factors shape immunity Nisha K. Duggal & Michael Emerman p687 | doi:10.1038/nri3295 The evolutionary 'arms race' between host restriction factors and viral antagonists has left a genetic 'signature' that can tell us much about the innate immune response to past and present viral infections. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| Dietary influences on intestinal immunity Marc Veldhoen & Verena Brucklacher-Waldert p696 | doi:10.1038/nri3299 Dietary habits have always been associated with the robustness of the immune system. Here, the molecular links between dietary compounds and immune regulation in the intestine are discussed, with a focus on the central role of nuclear receptors. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| Tools to therapeutically harness the human antibody response Patrick C. Wilson & Sarah F. Andrews p709 | doi:10.1038/nri3285 Here, Patrick Wilson and Sarah Andrews discuss the strategies that have been used to identify rare broadly neutralizing antibodies, focusing on the recent advances in isolating such antibodies naturally generated in response to HIV and influenza virus infection or vaccination. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| PERSPECTIVES | Top | ||||||||||||||||||||||||||||||||||||||||||||||
| OPINION Unconventional recognition of peptides by T cells and the implications for autoimmunity James F. Mohan & Emil R. Unanue p721 | doi:10.1038/nri3294 In this Opinion, the authors describe an unconventional form of peptide recognition that can allow potentially autoreactive CD4+ T cells to escape thymic regulation. They explain how these T cells respond to unstable peptide—MHC complexes that evade H2-DM-mediated editing, and they discuss the implications for autoimmunity. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| VIEWPOINT The impact of probiotics and prebiotics on the immune system Todd R. Klaenhammer, Michiel Kleerebezem, Matthias Volkmar Kopp & Maria Rescigno p728 | doi:10.1038/nri3312 Here, Nature Reviews Immunology asks four experts to share their thoughts on the ability of probiotics and prebiotics to modulate the immune system and influence disease. Can these products have a therapeutic application for inflammatory diseases? Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| SCIENCE AND SOCIETY Consortium biology in immunology: the perspective from the Immunological Genome Project Christophe Benoist, Lewis Lanier, Miriam Merad, Diane Mathis & the Immunological Genome Project p734 | doi:10.1038/nri3300 What is the role and value of consortium biology in immunology? Here, the participants of the Immunological Genome Project share their thoughts on the benefits and shortcomings of 'big science' and discuss how the immunology community can profit from engaging in this type of discovery-led research. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| CORRESPONDENCE | Top | ||||||||||||||||||||||||||||||||||||||||||||||
| Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial Christopher Horvath, Laura Andrews, Andreas Baumann, Lauren Black, Diann Blanset, Joy Cavagnaro, Kenneth L. Hastings, David L. Hutto, Timothy K. MacLachlan, Mark Milton, Theresa Reynolds, Stan Roberts, Mark Rogge, Jennifer Sims, George Treacy, Garvin Warner & James D. Green p740 | doi:10.1038/nri3192-c1 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| Response to 'Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial' Thomas Hünig p740 | doi:10.1038/nri3192-c2 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| Corrigendum: Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial Christopher Horvath, Laura Andrews, Andreas Baumann, Lauren Black, Diann Blanset, Joy Cavagnaro, Kenneth L. Hastings, David L. Hutto, Timothy K. MacLachlan, Mark Milton, Theresa Reynolds, Stan Roberts, Mark Rogge, Jennifer Sims, George Treacy, Garvin Warner & James D. Green p740 | doi:10.1038/nri3302 Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| *2011 Journal Citation Report (Thomson Reuters, 2012) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
![]() |











No comments:
Post a Comment